Atara Biotherapeutics, Inc.
ATRA
DELAYED 1 MONTH

12 insider filings · Latest: Jul 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 18, 2026May 20 9:24 PMAnhco NguyenDirector, President and CEO
Sale
5,241$9.13$47.8K137,837(D)

View →

May 18, 2026May 20 9:24 PMYanina Grant-HuertaChief Accounting Officer
Sale
2,414$9.13$22.0K49,636(D)

View →

May 7, 2026May 11 10:45 PMPanacea Innovation Ltd10% Owner
Sale
313,446$10.10$3.2M1,011,000(I)

View →

May 7, 2026May 11 9:34 PMEcoR1 Capital, LLC10% Owner
Purchase
507,407$9.35$4.7M1,552,000(I)

View →

Mar 2, 2026Mar 4 9:28 PMYanina Grant-HuertaChief Accounting Officer
Sale
2,104$5.08$10.7K31,750(D)

View →

Mar 2, 2026Mar 4 9:28 PMAnhco NguyenDirector, President and CEO
Sale
2,996$5.09$15.2K61,978(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 22, 2026Jul 25 1:00 AMRedmile Group, LLCDirector
Option Exercise
195,211—0(I)

View →